Igm Biosciences Inc Revenue per Employee (IGMS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Igm Biosciences Inc   (NASDAQ: IGMS)
 

Igm Biosciences Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 11353.19% in the second quarter 2025, year on year to cumulative value of $145 million, Igm Biosciences Inc 's revenue per employee grew on a trailing twelve months basis to $ 647,536. The productivity of Igm Biosciences Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Igm Biosciences Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Igm Biosciences Inc has 224 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IGMS Revenue per Employee (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Revenue Change 11353.19 % - -17.29 % 1.38 % -
Sales per Employee (TTM) $ 647,536 11,960 11,960 12,808 12,777
IGMS's Total Ranking # # # # #
Seq. Revenue Change - - 76.16 % -58.85 % -

IGMS Company Profile >> Back to IGMS Efficiency Comparisons >> Compare IGMS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 0 $ 0 $ 0
 



Financial Statements
Igm Biosciences Inc 's Revenue MRQ $ 144 Millions Visit IGMS's Income Statement
Igm Biosciences Inc 's Revenues TTM $ 145 Millions Visit IGMS's aggregate revenue growth
What are IGMS's Sales? Visit IGMS's Sales by Segment




Other Ratios
Igm Biosciences Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IGMS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IGMS's Competitors
Revenue per Employee for IGMS's Suppliers
Revenue per Employee for IGMS's Customers

You may also want to know
IGMS's Sales Growth Rates IGMS's Pe Price to earnings ratio IGMS's Receivables Turnover Ratio IGMS's Stock Quote
IGMS's Net Income Growth Rates IGMS's Ps Price to Sales ratio IGMS's Sales per Employee IGMS's Asset Turnover Ratio
IGMS's Net Margin IGMS's Pb Price to Book ratio IGMS's Financial Strength Ratios IGMS's Dividend Payout Ratio
Date modified: 2026-09-18T13:11:06+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
Amicus Therapeutics inc   1,115,393.35 $ 569.966  Million 511 
Arcturus Therapeutics Holdings Inc   1,100,198.20 $ 122.122  Million 111 
Marker Therapeutics inc   1,077,614.20 $ 5.388  Million 5 
Eli Lilly And Company  1,065,162.00 $ 53,258.100  Million 50,000 
Day One Biopharmaceuticals Inc   1,054,146.07 $ 187.638  Million 178 
Akebia Therapeutics Inc   1,050,170.10 $ 203.733  Million 194 
Abbvie Inc   1,023,298.25 $ 58,328.000  Million 57,000 
Apellis Pharmaceuticals Inc   1,021,174.56 $ 754.648  Million 739 
Lifevantage Corp  1,020,923.77 $ 227.666  Million 223 
Supernus Pharmaceuticals inc   1,020,130.37 $ 665.125  Million 652 
Zevra Therapeutics Inc   1,016,721.31 $ 62.020  Million 61 
Alnylam Pharmaceuticals Inc   984,785.20 $ 2,461.963  Million 2,500 
Corcept Therapeutics Inc  980,931.51 $ 716.080  Million 730 
Journey Medical Corp  972,362.07 $ 56.397  Million 58 
Coherus Oncology inc   971,231.29 $ 142.771  Million 147 
Fennec Pharmaceuticals Inc   951,485.71 $ 33.302  Million 35 
Biomarin Pharmaceutical Inc  951,135.67 $ 3,063.608  Million 3,221 
Emergent Biosolutions Inc   946,222.22 $ 851.600  Million 900 
Regeneron Pharmaceuticals Inc   922,401.04 $ 14,214.200  Million 15,410 
Esperion Therapeutics Inc   911,989.80 $ 268.125  Million 294 
Elutia Inc   906,923.08 $ 23.580  Million 26 
Sanara Medtech Inc   891,004.41 $ 96.228  Million 108 
Aytu Biopharma Inc  866,197.37 $ 65.831  Million 76 
Theravance Biopharma inc   857,833.33 $ 77.205  Million 90 
Pacira Biosciences inc   851,445.11 $ 705.848  Million 829 
Pfizer Inc  851,106.67 $ 63,833.000  Million 75,000 
Merck and Co Inc   848,213.33 $ 63,616.000  Million 75,000 
Carlisle Companies Incorporated  847,762.71 $ 5,001.800  Million 5,900 
Y mabs Therapeutics inc   847,210.00 $ 84.721  Million 100 
Xtant Medical Holdings Inc   846,748.34 $ 127.859  Million 151 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.